{"altmetric_id":1939698,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":4},"twitter":{"unique_users_count":2,"unique_users":["IJGConline","libbyshope"],"posts_count":4}},"selected_quotes":["CDK Inhibitor AZD7762 Overcomes Cisplatin Resistance in Ovarian Clear Cell Cancer."],"citation":{"abstract":"Checkpoint kinase (Chk) inhibitors are thought to increase the cytotoxic effects of DNA-damaging agents and are undergoing clinical trials. The present study was aimed to assess the potential to use the Chk1 and Chk2 inhibitor, AZD7762, with other anticancer agents in chemotherapy to treat ovarian clear cell carcinoma.","abstract_source":"pubmed","altmetric_jid":"4f6fa61d3cf058f6100078c8","doi":"10.1097\/igc.0000000000000014","first_seen_on":"2013-11-27T23:08:59+00:00","issns":["1048-891X"],"issue":"","journal":"International Journal of Gynecological Cancer","last_mentioned_on":1394151092,"links":["http:\/\/journals.lww.com\/ijgc\/Abstract\/publishahead\/Checkpoint_Kinase_Inhibitor_AZD7762_Overcomes.99241.aspx","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24362713","http:\/\/journals.lww.com\/ijgc\/Abstract\/2014\/01000\/Checkpoint_Kinase_Inhibitor_AZD7762_Overcomes.11.aspx"],"pdf_url":"http:\/\/pdfs.journals.lww.com\/ijgc\/9000\/00000\/Checkpoint_Kinase_Inhibitor_AZD7762_Overcomes.99241.pdf","pmid":"24362713","pubdate":"2013-11-21T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"","subjects":["neoplasms","gynecology"],"title":"Checkpoint Kinase Inhibitor AZD7762 Overcomes Cisplatin Resistance in Clear Cell Carcinoma of the Ovary","type":"article","volume":"Publish Ahead of Print","mendeley_url":"http:\/\/www.mendeley.com\/research\/checkpoint-kinase-inhibitor-azd7762-overcomes-cisplatin-resistance-clear-cell-carcinoma-ovary-1"},"altmetric_score":{"score":0.75,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.75},"context_for_score":{"all":{"total_number_of_other_articles":5040289,"mean":5.9643426109799,"rank":3355229,"this_scored_higher_than_pct":29,"this_scored_higher_than":1479987,"rank_type":"exact","sample_size":5040289,"percentile":29},"similar_age_3m":{"total_number_of_other_articles":128899,"mean":7.2797287467611,"rank":80482,"this_scored_higher_than_pct":33,"this_scored_higher_than":43437,"rank_type":"exact","sample_size":128899,"percentile":33},"this_journal":{"total_number_of_other_articles":1474,"mean":0.90392124915139,"rank":337,"this_scored_higher_than_pct":71,"this_scored_higher_than":1054,"rank_type":"exact","sample_size":1474,"percentile":71},"similar_age_this_journal_3m":{"total_number_of_other_articles":58,"mean":0.67894736842105,"rank":9,"this_scored_higher_than_pct":72,"this_scored_higher_than":42,"rank_type":"exact","sample_size":58,"percentile":72}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Unspecified":1},"by_discipline":{"Unspecified":1}}},"geo":{"twitter":{"US":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/IJGConline\/status\/405835599501746176","license":"public","citation_ids":[1939698],"posted_on":"2013-11-27T23:08:41+00:00","author":{"name":"IJGC","url":"http:\/\/ijgc.net","image":"https:\/\/pbs.twimg.com\/profile_images\/756209106717777920\/fvbA4WtA_normal.jpg","description":"IJGC is the primary publication for detection, prevention, diagnosis, and treatment of gynecologic malignancies. Emphasizes a multidisciplinary approach.","id_on_source":"IJGConline","tweeter_id":"174787278","geo":{"lt":null,"ln":null},"followers":197},"tweet_id":"405835599501746176"},{"url":"http:\/\/twitter.com\/libbyshope\/status\/415551834292375552","license":"public","citation_ids":[1939698],"posted_on":"2013-12-24T18:37:32+00:00","author":{"name":"Paul Cacciatore","url":"http:\/\/libbyshope.com","image":"https:\/\/pbs.twimg.com\/profile_images\/80719634\/HopeStreetSign_normal.jpg","description":"Founder of Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)","id_on_source":"libbyshope","tweeter_id":"21413951","geo":{"lt":34.05223,"ln":-118.24368,"country":"US"},"followers":1785},"tweet_id":"415551834292375552"},{"url":"http:\/\/twitter.com\/IJGConline\/status\/419806913132367872","license":"public","citation_ids":[1939698],"posted_on":"2014-01-05T12:25:42+00:00","author":{"name":"IJGC","url":"http:\/\/ijgc.net","image":"https:\/\/pbs.twimg.com\/profile_images\/756209106717777920\/fvbA4WtA_normal.jpg","description":"IJGC is the primary publication for detection, prevention, diagnosis, and treatment of gynecologic malignancies. Emphasizes a multidisciplinary approach.","id_on_source":"IJGConline","tweeter_id":"174787278","geo":{"lt":null,"ln":null},"followers":197},"tweet_id":"419806913132367872"},{"url":"http:\/\/twitter.com\/IJGConline\/status\/441727815746985984","license":"datasift","citation_ids":[1939698],"posted_on":"2014-03-07T00:11:32+00:00","author":{"name":"IJGC","url":"http:\/\/ijgc.net","image":"https:\/\/pbs.twimg.com\/profile_images\/756209106717777920\/fvbA4WtA_normal.jpg","description":"IJGC is the primary publication for detection, prevention, diagnosis, and treatment of gynecologic malignancies. Emphasizes a multidisciplinary approach.","id_on_source":"IJGConline","tweeter_id":"174787278","geo":{"lt":null,"ln":null},"followers":197},"tweet_id":"441727815746985984"}]}}